课题基金 / 基金详情

Aging, Fibroblast Senescence, and Apoptosis in Lung Fibrosis

Aging, Fibroblast Senescence, and Apoptosis in Lung Fibrosis
肺纤维化中的衰老、成纤维细胞衰老和细胞凋亡
批准号:
8971617
负责人:
LOUISE HECKER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-01 至 2017-05-31

项目摘要

项目成果

LOUISE HECKER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 特发性肺纤维化(IPF)是一种最终致命的疾病,其特征是进行性瘢痕组织形成导致呼吸衰竭。衰老与IPF之间有很强的相关性,然而很少有研究调查衰老对持续性肺纤维化易感性的影响。我们的初步研究表明,老年小鼠对肺损伤的反应表现出持续性的纤维化。我们先前报道了NOX4/H_2O_2在介导肌成纤维细胞功能和肺纤维化中的关键作用。然而,NOX4表达的年龄相关性变化以及NOX4/H_2O_2在介导促纤维化的肺肌成纤维细胞表型(衰老、抗凋亡)中的作用尚未见报道。在拟议的研究中,我们将探索这样的假设,即在衰老的背景下,NOX4通过积累衰老的肌成纤维细胞促进持续性纤维化,从而可能诱导上皮细胞凋亡。我们建议开发一种新的老年小鼠持续性纤维化的动物模型,更准确地模拟IPF患者的持续性/进行性纤维化。这些研究将提供:(1)用于IPF研究和临床前评估的更相关的体外和体内实验模型;(2)对衰老和IPF发病机制的新见解;(3)NOX4/H2O2在衰老中的扩大作用,以及进一步验证以NOX4为靶点治疗纤维化疾病的概念。
英文摘要
DESCRIPTION (provided by applicant): Idiopathic pulmonary fibrosis (IPF) is an ultimately fatal disease, characterized by progressive scar tissue formation leading to respiratory failure. There is a strong association between aging and IPF, however few studies have investigated the effects of aging on susceptibility to persistent lung fibrosis. Our preliminary studies indicate that aged mice exhibit persistent fibrosis in response to lung injury. We previously reported a critical role for NOX4/H2O2 in mediating myofibroblast functions and lung fibrosis. However, age-associated alterations in NOX4 expression as well as the role of NOX4/H2O2 in mediating pro-fibrotic lung myofibroblast phenotypes (senescence, apoptosis-resistance) have not previously been reported. The proposed studies, we will explore the hypothesis that, in the context of aging, NOX4 contributes to persistent fibrosis by the accumulation of senescent myofibroblasts, which may then induce apoptosis of epithelial cells. We propose to develop a novel animal model of persistent fibrosis in aged mice, which more accurately mimics the persistent/progressive fibrosis seen in IPF patients. These studies will provide: (1) more relevant ex vivo and in vivo experimental models for investigation of IPF and pre-clinical evaluation; (2) novel insights into the role of aging andin the pathogenesis of IPF; and, (3) expanded roles of NOX4/H2O2 in aging and further proof-of-concept for therapeutic targeting NOX4 in fibrotic diseases.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Aging and ARDS: Novel Mechanistic Role of Nox4/D in Age-Dependent Barrier Dysfunction
  • 批准号:
    10485562
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    LOUISE HECKER
  • 依托单位:
3D High Throughput Model to Predict Drug Efficacy in Fibrosis Progression vs Reversal
  • 批准号:
    9975675
  • 项目类别:
  • 资助金额:
    $23.5万
  • 财政年份:
    2019
  • 负责人:
    LOUISE HECKER
  • 依托单位:
Preclinical development of a novel Nrf2-activator formulation for the treatment of idiopathic pulmonary fibrosis
  • 批准号:
    9224281
  • 项目类别:
  • 资助金额:
    $18.87万
  • 财政年份:
    2017
  • 负责人:
    LOUISE HECKER
  • 依托单位:
The role of Nampt in age-associated persistent lung fibrosis
  • 批准号:
    10046286
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    LOUISE HECKER
  • 依托单位:
海外基金